close
MENU
Investment
3 mins to read

Syft sale not a certainty as strategic adviser tests market – CEO

Mass spectrometer company’s new pharmaceutical-focused product has been released this month.

Syft’s fears that it relied on too few customers came true in FY23.

Will Mace Wed, 27 Sep 2023

Syft Technologies is not on a single track towards a sale, according to CEO Alex Fala, despite engaging an adviser to investigate strategic options for the business. 

The strategic review was a condition of the USX-listed company’s recent $5.5 million capital raise, which saw the company’s

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Will Mace Wed, 27 Sep 2023
Contact the Writer: william@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Syft sale not a certainty as strategic adviser tests market – CEO
Investment,
101023
true